TPG inks $1.9bn pharma take-private

The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.

ByGraham Winfrey

14 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals People North America Fund Management

TPG inks $1.9bn pharma take-private

TPG

Goldman Sachs